Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction.
BACKGROUND
The presence and extent of microvascular obstruction (MO) after acute myocardial infarction can be measured by first-pass gadolinium-enhanced perfusion cardiovascular magnetic resonance (CMR) or after gadolinium injection with early or late enhancement (EGE/LGE) imaging. The volume of MO measured by these three methods may differ because contrast agent diffusion into the MO reduces its apparent extent over time. Theoretically, first-pass perfusion CMR should be the most accurate method to measure MO, but this technique has been limited by lower spatial resolution than EGE and LGE as well as incomplete cardiac coverage. These limitations of perfusion CMR can be overcome using spatio-temporal undersampling methods. The purpose of this study was to compare the extent of MO by high resolution first-pass k-t SENSE accelerated perfusion, EGE and LGE.


METHODS
34 patients with acute ST elevation myocardial infarction, treated successfully with primary percutaneous coronary intervention (PPCI), underwent CMR within 72 hours of admission. k-t SENSE accelerated first-pass perfusion MR (7 fold acceleration, spatial resolution 1.5 mm x 1.5 mm x 10 mm, 8 slices acquired over 2 RR intervals, 0.1 mmol/kg Gd-DTPA), EGE (14 minutes after injection with a fixed TI of 440 ms) and LGE images (1012 minutes after injection, TI determined by a Look-Locker scout) were acquired. MO volume was determined for each technique by manual planimetry and summation of discs methodology.


RESULTS
k-t SENSE first-pass perfusion detected more cases of MO than EGE and LGE (22 vs. 20 vs. 14, respectively). The extent of MO imaged by first-pass perfusion (median mass 4.7 g, IQR 6.7) was greater than by EGE (median mass 2.3 g, IQR 7.1, p = 0.002) and LGE (median mass 0.2 g, IQR 2.4, p = 0.0003). The correlation coefficient between MO mass measured by first-pass perfusion and EGE was 0.91 (p < 0.001).


CONCLUSIONS
The extent of MO following acute myocardial infarction appears larger on high-resolution first-pass perfusion CMR than on EGE and LGE. Given the inevitable time delay between gadolinium administration and acquisition of either EGE or LGE images, high resolution first-pass perfusion imaging may be the most accurate method to quantify MO.
Mather
Adam N
AN
Division of Cardiovascular and Neuronal Remodelling, University of Leeds, UK. sa.n.mather@doctors.org.uk
Lockie
Timothy
T
Nagel
Eike
E
Marber
Michael
M
Perera
Divaka
D
Redwood
Simon
S
Radjenovic
Aleksandra
A
Saha
Ansuman
A
Greenwood
John P
JP
Plein
Sven
S
D015906:Angioplasty, Balloon, Coronary; D003287:Contrast Media / Q000008:administration & dosage; D003326:Coronary Circulation; D003331:Coronary Vessels / Q000473:pathology* / Q000503:physiopathology; D004739:England; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D055806:Microvessels / Q000473:pathology* / Q000503:physiopathology; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000473:pathology* / Q000503:physiopathology / Q000628:therapy; D055414:Myocardial Perfusion Imaging / Q000379:methods*; D054318:No-Reflow Phenomenon / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology; D015588:Observer Variation; D011237:Predictive Value of Tests; D015203:Reproducibility of Results
D003287:Contrast Media; D019786:Gadolinium DTPA
J Cardiovasc Magn Reson. 2006;8(6):831-7
17060106
Lancet. 2003 Jan 4;361(9351):13-20
12517460
N Engl J Med. 1993 Mar 11;328(10):673-9
8433725
Circulation. 1992 May;85(5):1699-705
1572028
Circulation. 1995 Sep 1;92(5):1117-25
7648655
Circulation. 1998 Jun 16;97(23):2302-6
9639373
J Cardiovasc Magn Reson. 2004;6(4):917-25
15646895
Eur Heart J. 2005 Mar;26(6):549-57
15713695
Circulation. 1996 Dec 15;94(12):3318-26
8989146
Circulation. 1996 Jan 15;93(2):223-8
8548892
Am J Cardiol. 2002 Jul 1;90(1):29-34
12088775
Circulation. 2004 Jun 29;109(25):3096-105
15226226
J Am Coll Cardiol. 2000 Oct;36(4):1202-9
11028471
Circulation. 1995 Oct 1;92(7):1902-10
7671375
Circulation. 1999 Feb 16;99(6):744-50
9989958
Circulation. 1996 Mar 1;93(5):879-88
8598078
J Clin Invest. 1974 Dec;54(6):1496-508
4140198
Circulation. 1998 Sep 8;98(10):1006-14
9737521
Circulation. 1999 Nov 9;100(19):1992-2002
10556226
Magn Reson Med. 2007 Oct;58(4):777-85
17899611
Circulation. 2000 Feb 8;101(5):570-80
10662756
Circulation. 2004 May 4;109(17):2080-5
15117844
J Am Coll Cardiol. 1998 Nov 15;32(6):1756-64
9822106
Radiology. 2004 Jul;232(1):49-57
15166320
Circulation. 2000 Jan 18;101(2):125-30
10637197
J Am Coll Cardiol. 2008 Jul 15;52(3):181-9
18617066
Circulation. 1998 Mar 3;97(8):765-72
9498540
Eur Radiol. 2006 Mar;16(3):551-9
16215736
J Am Coll Cardiol. 2001 Jan;37(1):9-18
11153779